IGF1 and cancer: Indeed, in contrast to liver, muscle and adipose tissue where diabetes-induced increase in plasma insulin is compensated by diabetic insulin resistance, insulin-sensitive cancer cells in the diabetes context are exposed to high insulin and IGF-1 acting as growth factors.